SSSI issued for nicorandil tablets

Forecast intermittent shortages of nicorandil prompt regulator to announce SSSI  Pharmacists are being authorised to substitute brand and strength of nicorandil products without patients needing a new prescription under a Serious Scarcity Substitution Instrument (SSSI) issued last week (Friday 28 November 2025).   Announcing the SSSI, Therapeutic Goods Administration (TGA) reported that supplies of 10 mg and 20 mg strengths of  Arrotex’s APO-Nicorandil and Ikotab from Viatris,